Showing results (761-770 of 1,019) with videos related to
Sort By:
Pageof 102
Clinicoeconomics and Outcomes Research : CEOR|April 2, 2026
Effect of Drug Cost-Exemption Policy on Treatment Outcomes in Multidrug-Resistant Tuberculosis Patients in Guangxi Zhuang Autonomous Region, China: A Nested Case-Control StudyAimei Liu, Yan Liao, Juexian Ye, et al.Clinicoeconomics and Outcomes Research : CEOR|April 13, 2026
A Cost Analysis of Adverse Event Management of Systemic Therapies for Metastatic Colorectal Cancer on Patients with at Least Two Previous Lines of Treatment in SpainAna Fernández, Beatriz González Astorga, Nuria Rodríguez, et al.Clinicoeconomics and Outcomes Research : CEOR|July 31, 2023
Weight and BMI Changes Following Initiation of Emtricitabine/Tenofovir Alafenamide Co-Formulated with Darunavir or Co-Administered with Dolutegravir in Overweight or Obese, ART-Naïve People Living with HIV-1Prina Donga, Bruno Emond, Carmine Rossi, et al.Clinicoeconomics and Outcomes Research : CEOR|July 14, 2026
Transition from Free to Paid Vaccination: Willingness to Pay for COVID-19 Booster Doses in Vietnam in the Post-Pandemic EraThanh Van Nguyen, Cuong Tat Nguyen, Trang Huyen Bui, et al.Clinicoeconomics and Outcomes Research : CEOR|May 27, 2026
Nivolumab-AVD versus Brentuximab Vedotin-AVD as First-Line Treatment for Advanced-Stage Classical Hodgkin Lymphoma: A Cost-Effectiveness AnalysisBiao Li, Jingjing Yang, Jing Li, et al.Clinicoeconomics and Outcomes Research : CEOR|May 11, 2026
Economic Burden of Overall and Advanced Light Chain Amyloidosis: Results from a Claims Linked Electronic Health Record Database AnalysisJeffrey A Thompson, Ankita Gupta, Julia Catini, et al.Clinicoeconomics and Outcomes Research : CEOR|October 17, 2022
Costs by Site of Service for Commercially-Insured Patients with Metastatic Pancreatic Cancer Receiving Guideline-Recommended Chemotherapy: Comparing Community Oncology and Hospital Outpatient SettingsSamantha Tomicki, Gabriela Dieguez, David DeStephano, et al.Clinicoeconomics and Outcomes Research : CEOR|May 25, 2016
A burden of illness study for neuropathic pain in EuropeHiltrud Liedgens, Marko Obradovic, Jonathan De Courcy, et al.Clinicoeconomics and Outcomes Research : CEOR|July 3, 2013
The clinical and economic burden of chronic obstructive pulmonary disease in the USAAnthony J Guarascio, Shauntá M Ray, Christopher K Finch, et al.Clinicoeconomics and Outcomes Research : CEOR|July 18, 2013
A cost-of-illness study of spina bifida in ItalyGiorgio L Colombo, Sergio Di Matteo, Marta Vinci, et al.Pageof 102